Journey Medical (DERM) Competitors $7.46 -0.04 (-0.53%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$7.51 +0.05 (+0.67%) As of 10/24/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM vs. FBIO, RZLT, NRIX, DAWN, AKBA, OLMA, TYRA, TERN, TBPH, and ARVNShould you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Fortress Biotech (FBIO), Rezolute (RZLT), Nurix Therapeutics (NRIX), Day One Biopharmaceuticals (DAWN), Akebia Therapeutics (AKBA), Olema Pharmaceuticals (OLMA), Tyra Biosciences (TYRA), Terns Pharmaceuticals (TERN), Theravance Biopharma (TBPH), and Arvinas (ARVN). These companies are all part of the "medical" sector. Journey Medical vs. Its Competitors Fortress Biotech Rezolute Nurix Therapeutics Day One Biopharmaceuticals Akebia Therapeutics Olema Pharmaceuticals Tyra Biosciences Terns Pharmaceuticals Theravance Biopharma Arvinas Fortress Biotech (NASDAQ:FBIO) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings. Does the media prefer FBIO or DERM? In the previous week, Fortress Biotech and Fortress Biotech both had 6 articles in the media. Journey Medical's average media sentiment score of 0.89 beat Fortress Biotech's score of 0.36 indicating that Journey Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortress Biotech 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Journey Medical 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate FBIO or DERM? Fortress Biotech currently has a consensus target price of $16.50, suggesting a potential upside of 557.37%. Journey Medical has a consensus target price of $12.17, suggesting a potential upside of 63.09%. Given Fortress Biotech's higher possible upside, equities analysts plainly believe Fortress Biotech is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortress Biotech 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Journey Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Is FBIO or DERM more profitable? Journey Medical has a net margin of -15.49% compared to Fortress Biotech's net margin of -24.84%. Journey Medical's return on equity of -48.69% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Fortress Biotech-24.84% -301.81% -27.48% Journey Medical -15.49%-48.69%-11.26% Do institutionals and insiders hold more shares of FBIO or DERM? 96.5% of Fortress Biotech shares are held by institutional investors. Comparatively, 7.3% of Journey Medical shares are held by institutional investors. 27.9% of Fortress Biotech shares are held by insiders. Comparatively, 15.0% of Journey Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger valuation and earnings, FBIO or DERM? Journey Medical has lower revenue, but higher earnings than Fortress Biotech. Journey Medical is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortress Biotech$57.67M1.29-$46M-$1.05-2.39Journey Medical$56.13M3.50-$14.67M-$0.38-19.63 Which has more volatility & risk, FBIO or DERM? Fortress Biotech has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. SummaryJourney Medical beats Fortress Biotech on 9 of the 15 factors compared between the two stocks. Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DERM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DERM vs. The Competition Export to ExcelMetricJourney MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$196.27M$2.62B$6.21B$10.81BDividend YieldN/A57.77%5.72%4.80%P/E Ratio-19.6328.3731.6030.98Price / Sales3.50786.95595.06133.64Price / CashN/A168.8137.2561.86Price / Book8.205.6512.056.61Net Income-$14.67M$33.06M$3.34B$277.10M7 Day Performance3.61%3.16%1.94%2.57%1 Month Performance5.67%7.06%6.88%3.20%1 Year Performance29.51%-2.15%56.06%33.22% Journey Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DERMJourney Medical1.902 of 5 stars$7.46-0.5%$12.17+63.1%+29.5%$196.27M$56.13M-19.6390News CoverageAnalyst ForecastFBIOFortress Biotech2.7121 of 5 stars$2.80+3.3%$16.50+489.3%+35.7%$80.64M$57.67M-2.67170News CoverageAnalyst ForecastRZLTRezolute2.6068 of 5 stars$8.07-2.4%$14.50+79.7%+59.0%$751.15MN/A-8.3240News CoverageAnalyst ForecastGap UpNRIXNurix Therapeutics2.0887 of 5 stars$9.72-0.4%$27.93+187.3%-57.8%$750.38M$54.55M-3.27300Trending NewsAnalyst ForecastAnalyst RevisionDAWNDay One Biopharmaceuticals2.9849 of 5 stars$7.19-0.7%$25.29+251.7%-48.7%$741.61M$131.16M-7.5760AKBAAkebia Therapeutics3.5152 of 5 stars$2.78+1.1%$6.75+142.8%+90.6%$729.15M$160.18M-16.35430Analyst ForecastOLMAOlema Pharmaceuticals3.1215 of 5 stars$10.75+1.7%$23.33+117.1%-30.5%$725.47MN/A-5.4370Analyst ForecastGap DownTYRATyra Biosciences2.4122 of 5 stars$14.36+6.2%$31.86+121.8%-35.1%$720.58MN/A-8.0720Analyst ForecastTERNTerns Pharmaceuticals4.02 of 5 stars$8.20+0.6%$15.49+88.9%+16.5%$713.22MN/A-7.8840News CoverageAnalyst ForecastTBPHTheravance Biopharma2.1598 of 5 stars$13.92-0.5%$23.00+65.2%+67.0%$704.55M$64.38M58.00110News CoverageAnalyst ForecastARVNArvinas3.6087 of 5 stars$9.80+3.6%$16.29+66.2%-64.5%$694.53M$263.40M-9.70420News CoverageUpcoming EarningsAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies Fortress Biotech Competitors Rezolute Competitors Nurix Therapeutics Competitors Day One Biopharmaceuticals Competitors Akebia Therapeutics Competitors Olema Pharmaceuticals Competitors Tyra Biosciences Competitors Terns Pharmaceuticals Competitors Theravance Biopharma Competitors Arvinas Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DERM) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DERM Stock Alerts